title: Changing oral vaccine to inactivated polio vaccine might increase mortality.
authors.affiliation: Toronto General Research Institute, University Health Network, Toronto, ON M5G 2M1, Canada; University of Toronto, Toronto, ON, Canada. Electronic address: en.fish@utoronto.ca.
authors.forename: Eleanor N
authors.initials: EN
authors.lastname: Fish
authors.affiliation: Monash University, Melbourne, VIC, Australia; University of Tasmania, Hobart, TAS, Australia.
authors.forename: Kate L
authors.initials: KL
authors.lastname: Flanagan
authors.affiliation: School of Medicine, Stanford University, Stanford, CA, USA; Systems Biology Department, Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar.
authors.forename: David
authors.initials: D
authors.lastname: Furman
authors.affiliation: Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
authors.forename: Sabra L
authors.initials: SL
authors.lastname: Klein
authors.affiliation: University of British Columbia, Vancouver, BC, Canada.
authors.forename: Tobias R
authors.initials: TR
authors.lastname: Kollmann
authors.affiliation: Copenhagen University Hvidore Hospital, Copenhagen, Denmark.
authors.forename: Dorthe L
authors.initials: DL
authors.lastname: Jeppesen
authors.affiliation: Boston's Children's Hospital, Harvard Medical School, Boston, MA, USA.
authors.forename: Ofer
authors.initials: O
authors.lastname: Levy
authors.affiliation: Institute for Medical Immunology, Université Libre de Bruxelles, Brussels, Belgium.
authors.forename: Arnaud
authors.initials: A
authors.lastname: Marchant
authors.affiliation: Royal Children's Hospital, Melbourne, VIC, Australia.
authors.forename: Siva
authors.initials: S
authors.lastname: Namachivayam
authors.affiliation: Radboud University Medical Center, Nijmegen, Netherlands.
authors.forename: Mihai G
authors.initials: MG
authors.lastname: Netea
authors.affiliation: Monash University, Melbourne, VIC, Australia.
authors.forename: Magdalena
authors.initials: M
authors.lastname: Plebanski
authors.affiliation: Nuffield Department of Medicine, University of Oxford, Oxford, UK.
authors.forename: Sarah L
authors.initials: SL
authors.lastname: Rowland-Jones
authors.affiliation: University of Massachusetts Medical School, Worcester, MA, USA.
authors.forename: Liisa K
authors.initials: LK
authors.lastname: Selin
authors.affiliation: University of Melbourne, Melbourne, VIC, Australia.
authors.forename: Frank
authors.initials: F
authors.lastname: Shann
authors.affiliation: London School of Hygiene & Tropical Medicine, London, UK.
authors.forename: Hilton C
authors.initials: HC
authors.lastname: Whittle
mesh_terms: D057915:Drug Substitution; D005260:Female; D006801:Humans; D008297:Male; D011051:Poliomyelitis / Q000401:mortality* / Q000517:prevention & control; D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral / Q000009:adverse effects*
chemical_list: D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral